CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Posted
August 5, 2026
Views
2,702
Likes
13
Engagement
0.48%
August 5, 2026
2,702
13
0.48%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
1:33Now PlayingEli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro surged again.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
